Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium
Miguel García-Pardo(Hospital Universitario Ramón y Cajal), Geoffrey Liu(Princess Margaret Cancer Centre), Sanjay Shete(The University of Texas MD Anderson Cancer Center), Angeline S. Andrew(Dartmouth College), Guillermo Fernández‐Tardón(Universidad de Oviedo), Bríd M. Ryan(National Cancer Institute), Rui Manuel Reis(University of Minho), M. Catherine Brown(University Health Network), Matthew B. Schabath(Moffitt Cancer Center), Letícia Ferro Leal(Universidade de São Paulo), Hermann Brenner(German Cancer Research Center), Paul E. Brennan(University of Oxford), Sabine Schmid(University of Bern), David C. Christiani(Harvard University), Hilary Aurora Tindel(Vanderbilt University Medical Center), Jie Zhang(The University of Texas MD Anderson Cancer Center), Mei Dong(Cornell University), Chu Chen(University of Washington), Amy Chang(University Health Network), Давид Заридзе(Russian Cancer Research Center NN Blokhin), Wei Xu(University Health Network), Adonina Tardón(Universidad de Oviedo)
Cited by 26
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures
|Biostatistics|2014|1.8k